We’re putting the EMPHASIS back on CELIAC DISEASE .

Thinking of taking a trip to the Bay area? Check out these three restaurants, all of which are totally gluten-free!

Han will use the $180,000 grant to investigate the role of CD8 T-cells in celiac disease 

By participating in Summer Beyond Celiac, every member of our community can be part of this movement to find treatments and a cure.

This May we will once again be lacing up our shoes to get 3.1 miles closer to a cure. Register for our Step Beyond Celiac 5K to help us raise money for celiac disease research!

Ambassador Christina Heiser recaps her experience attending the 2022 Beyond Celiac Research Summit in Baltimore, Maryland.

At the recent Beyond Celiac Research Summit, scientists presented details of celiac disease studies exploring immune reactions, the gut-brain connection, the effect of screening for diagnosis among children and the interpretation of biopsy results. Read what they had to say in two research news posts.

Young adults who had been diagnosed with celiac disease as part of a broad screening program when they were kids have often abandoned the gluten-free diet, according to an 20-year follow-up Italian study.

Cystic fibrosis patients banded together and changed the future for those living with the disease. Can increased patient participation produce similar results for celiac disease?

An Increased risk of cancer in celiac disease is small and limited to diagnosis after 40, according to a new study from Sweden

Ask a Dietitian: What are dietary supplements you would recommend for a patient diagnosed with celiac disease?

Foods for when you suffer from both celiac disease and diverticulitis

Monitoring celiac disease

How to tell if ongoing symptoms are from celiac disease

What’s the point of follow-up testing and monitoring?

Cystic fibrosis patients banded together and changed the future for those living with the disease. Can increased patient participation produce similar results for celiac disease?

Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials

PRV-015 has previously been studied for its potential to reduce symptoms and inflammation triggered by gluten in people with celiac disease.

Latiglutenase development continues with initial CeliacShield™ study results and ongoing Solutions for Celiac™ clinical study actively recruiting participants

Celiac disease community is an integral part of research into this potential immune tolerance treatment